Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds.

Tian X, Werner ME, Roche KC, Hanson AD, Foote HP, Yu SK, Warner SB, Copp JA, Lara H, Wauthier EL, Caster JM, Herring LE, Zhang L, Tepper JE, Hsu DS, Zhang T, Reid LM, Wang AZ.

Nat Biomed Eng. 2018;2:443-452. Epub 2018 Apr 23.

2.

Effectiveness of Rotating Shield Brachytherapy for Prostate Cancer Dose Escalation and Urethral Sparing.

Adams Q, Hopfensperger KM, Kim Y, Wu X, Xu W, Shukla H, McGee J, Caster JM, Flynn RT.

Int J Radiat Oncol Biol Phys. 2018 Aug 6. pii: S0360-3016(18)33483-7. doi: 10.1016/j.ijrobp.2018.07.2015. [Epub ahead of print]

PMID:
30092333
3.

Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture.

Myung JH, Eblan MJ, Caster JM, Park SJ, Poellmann MJ, Wang K, Tam KA, Miller SM, Shen C, Chen RC, Zhang T, Tepper JE, Chera BS, Wang AZ, Hong S.

Clin Cancer Res. 2018 Jun 1;24(11):2539-2547. doi: 10.1158/1078-0432.CCR-17-3078. Epub 2018 Mar 15.

PMID:
29545463
4.

Applying nanotherapeutics to improve chemoradiotherapy treatment for cancer.

Caster JM, Wang AZ.

Ther Deliv. 2017 Aug;8(9):791-803. doi: 10.4155/tde-2017-0043. Review.

PMID:
28825397
5.

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.

Min Y, Roche KC, Tian S, Eblan MJ, McKinnon KP, Caster JM, Chai S, Herring LE, Zhang L, Zhang T, DeSimone JM, Tepper JE, Vincent BG, Serody JS, Wang AZ.

Nat Nanotechnol. 2017 Sep;12(9):877-882. doi: 10.1038/nnano.2017.113. Epub 2017 Jun 26.

6.

Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy.

Caster JM, Yu SK, Patel AN, Newman NJ, Lee ZJ, Warner SB, Wagner KT, Roche KC, Tian X, Min Y, Wang AZ.

Nanomedicine. 2017 Jul;13(5):1673-1683. doi: 10.1016/j.nano.2017.03.002. Epub 2017 Mar 11.

7.

Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer.

Tian J, Min Y, Rodgers Z, Wan X, Qiu H, Mi Y, Tian X, Wagner KT, Caster JM, Qi Y, Roche K, Zhang T, Cheng J, Wang AZ.

Nanomedicine. 2017 Apr;13(3):1301-1307. doi: 10.1016/j.nano.2016.11.007. Epub 2016 Nov 21.

8.

CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α.

Tian X, Nguyen M, Foote HP, Caster JM, Roche KC, Peters CG, Wu P, Jayaraman L, Garmey EG, Tepper JE, Eliasof S, Wang AZ.

Cancer Res. 2017 Jan 1;77(1):112-122. doi: 10.1158/0008-5472.CAN-15-2951. Epub 2016 Oct 26. Erratum in: Cancer Res. 2017 Dec 1;77(23 ):6790-6791.

9.

Preclinical Evaluation of Promitil, a Radiation-Responsive Liposomal Formulation of Mitomycin C Prodrug, in Chemoradiotherapy.

Tian X, Warner SB, Wagner KT, Caster JM, Zhang T, Ohana P, Gabizon AA, Wang AZ.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):547-55. doi: 10.1016/j.ijrobp.2016.06.2457. Epub 2016 Jul 1.

PMID:
27681751
10.

Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.

Caster JM, Patel AN, Zhang T, Wang A.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jan;9(1). doi: 10.1002/wnan.1416. Epub 2016 Jun 16. Review.

PMID:
27312983
11.

Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic.

Au KM, Satterlee A, Min Y, Tian X, Kim YS, Caster JM, Zhang L, Zhang T, Huang L, Wang AZ.

Biomaterials. 2016 Mar;82:178-93. doi: 10.1016/j.biomaterials.2015.12.018. Epub 2015 Dec 20.

12.

Direct Observation of Early-Stage High-Dose Radiotherapy-Induced Vascular Injury via Basement Membrane-Targeting Nanoparticles.

Au KM, Hyder SN, Wagner K, Shi C, Kim YS, Caster JM, Tian X, Min Y, Wang AZ.

Small. 2015 Dec 22;11(48):6404-10. doi: 10.1002/smll.201501902. Epub 2015 Nov 18.

13.

Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug delivery.

Tian X, Lara H, Wagner KT, Saripalli S, Hyder SN, Foote M, Sethi M, Wang E, Caster JM, Zhang L, Wang AZ.

Nanoscale. 2015 Dec 21;7(47):20211-9. doi: 10.1039/c5nr05869d. Epub 2015 Nov 17.

14.

Improving Cancer Chemoradiotherapy Treatment by Dual Controlled Release of Wortmannin and Docetaxel in Polymeric Nanoparticles.

Au KM, Min Y, Tian X, Zhang L, Perello V, Caster JM, Wang AZ.

ACS Nano. 2015 Sep 22;9(9):8976-96. doi: 10.1021/acsnano.5b02913. Epub 2015 Aug 25.

15.

Clinical Translation of Nanomedicine.

Min Y, Caster JM, Eblan MJ, Wang AZ.

Chem Rev. 2015 Oct 14;115(19):11147-90. doi: 10.1021/acs.chemrev.5b00116. Epub 2015 Jun 19. Review. No abstract available.

16.

Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients.

Caster JM, Falchook AD, Hendrix LH, Chen RC.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):244-51. doi: 10.1016/j.ijrobp.2015.01.051. Epub 2015 Apr 1.

PMID:
25841621
17.

Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors.

Wang EC, Min Y, Palm RC, Fiordalisi JJ, Wagner KT, Hyder N, Cox AD, Caster JM, Tian X, Wang AZ.

Biomaterials. 2015 May;51:208-215. doi: 10.1016/j.biomaterials.2015.02.015. Epub 2015 Feb 19.

18.

Nanoparticle delivery of chemosensitizers improve chemotherapy efficacy without incurring additional toxicity.

Caster JM, Sethi M, Kowalczyk S, Wang E, Tian X, Nabeel Hyder S, Wagner KT, Zhang YA, Kapadia C, Man Au K, Wang AZ.

Nanoscale. 2015 Feb 14;7(6):2805-11. doi: 10.1039/c4nr07102f.

19.

Individual differences in psychostimulant responses of female rats are associated with ovarian hormones and dopamine neuroanatomy.

Walker QD, Johnson ML, Van Swearingen AE, Arrant AE, Caster JM, Kuhn CM.

Neuropharmacology. 2012 Jun;62(7):2267-77. doi: 10.1016/j.neuropharm.2012.01.029. Epub 2012 Feb 8.

20.

Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.

Walker QD, Morris SE, Arrant AE, Nagel JM, Parylak S, Zhou G, Caster JM, Kuhn CM.

J Pharmacol Exp Ther. 2010 Oct;335(1):124-32. doi: 10.1124/jpet.110.167320. Epub 2010 Jul 6.

21.

Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models.

Schramm-Sapyta NL, Walker QD, Caster JM, Levin ED, Kuhn CM.

Psychopharmacology (Berl). 2009 Sep;206(1):1-21. doi: 10.1007/s00213-009-1585-5. Epub 2009 Jun 23. Review.

22.

Maturation of coordinated immediate early gene expression by cocaine during adolescence.

Caster JM, Kuhn CM.

Neuroscience. 2009 Apr 21;160(1):13-31. doi: 10.1016/j.neuroscience.2009.01.001. Epub 2009 Jan 7.

23.

Novelty-induced locomotion is positively associated with cocaine ingestion in adolescent rats; anxiety is correlated in adults.

Walker QD, Schramm-Sapyta NL, Caster JM, Waller ST, Brooks MP, Kuhn CM.

Pharmacol Biochem Behav. 2009 Jan;91(3):398-408. doi: 10.1016/j.pbb.2008.08.019. Epub 2008 Aug 28.

24.

Gonadal steroids mediate the opposite changes in cocaine-induced locomotion across adolescence in male and female rats.

Parylak SL, Caster JM, Walker QD, Kuhn CM.

Pharmacol Biochem Behav. 2008 May;89(3):314-23. doi: 10.1016/j.pbb.2008.01.003. Epub 2008 Jan 16.

25.

A single high dose of cocaine induces differential sensitization to specific behaviors across adolescence.

Caster JM, Walker QD, Kuhn CM.

Psychopharmacology (Berl). 2007 Aug;193(2):247-60. Epub 2007 Apr 11.

PMID:
17426961
26.

Enhanced behavioral response to repeated-dose cocaine in adolescent rats.

Caster JM, Walker QD, Kuhn CM.

Psychopharmacology (Berl). 2005 Dec;183(2):218-25. Epub 2005 Nov 9. Erratum in: Psychopharmacology (Berl). 2006 Jan;183(4):506.

PMID:
16175404

Supplemental Content

Loading ...
Support Center